News & Scientific Highlights

An international team of scientists from the Paul Scherrer Institute and members of the LeadXpro and Heptares pharmaceutical companies led by Karol Nass (Alvra group, SwissFEL) demonstrated a significant advancement in de novo protein structure determination at X-ray free-electron lasers. Their article, published recently in IUCrJ (DOI: 10.1107/S2052252520011379), describes structure determination of a membrane protein and an important drug target (A_2A adenosine receptor) by native single-wavelength anomalous diffraction (native-SAD) at SwissFEL with up to ten fold reduction in the required number of indexed images.

The results from the very first user experiment at SwissFEL have just been published in the Proceedings of the National Academy of Sciences (PNAS). The measurements probed the electron transport properties of the cytochrome c protein, which is found in cellular mitochondria. The measurements show that when the Fe atom at the centre of the protein undergoes electronic excitation, for example when it gains or loses and electron, the  active centre of the protein undergoes a doming structural rearrangement. This result raises interesting questions about how this structural change is involved in the electron transfer properties of cytochrome c.

The typical mode of operation at XFEL facilities uses the so-called self-amplified spontaneous emission (SASE) process to generate the short, bright X-ray pulses. This mode of operation is stochastic in nature, causing some variance in intensity and spectrum on a shot-to-shot basis, which makes certain types of crystallographic measurements much more challenging.

The high brilliance of new X-ray sources such as X-ray Free Electron Laser opens the way to non-linear spectroscopies. These techniques can probe ultrafast matter dynamics that would otherwise be inaccessible. One of these techniques, Transient Grating, involves the creation of a transient excitation grating by crossing X-ray beams on the sample. Scientists at PSI have realized a demonstration of such crossing by using an innovative approach well suited for the hard X-ray regime.

A major milestone in the commissioning of SwissFEL has been reached: the first pump-probe experiments on proteins have been successfully carried out. Crystals of several retinal-binding proteins were delivered in a viscous jet system and a femtosecond laser was used to start the isomerization reaction. Microsecond to sub-picosecond snapshots were then collected, catching the retinal proteins shortly after isomerization of the chromophore.

On the 7th to 12th of August 2018, a collaborative group of scientists from the Paul Scherrer Institute and members of the LeadXpro and Heptares pharmaceutical companies led by Karol Nass (PSI macromolecular crystallography MX-SLS group) performed the first serial femtosecond crystallography (SFX) pilot user experiment at the SwissFEL X-ray free electron laser (XFEL).

On the 17th of December 2017 SwissFEL saw its first pilot experiment in the Alvra experimental station of the SwissFEL ARAMIS beamline.